Hagiwara Junya, DellaVolpe Jeffrey D, Matsuzaki Yuichi
Institute for Extracorporeal Life Support, San Antonio, TX 78229, USA.
Texas IPS, San Antonio, TX 78229, USA.
J Funct Biomater. 2025 Jun 19;16(6):226. doi: 10.3390/jfb16060226.
Extracorporeal membrane oxygenation (ECMO) is a crucial life support therapy for patients with severe cardiac and respiratory failure. However, the complications associated with venoarterial ECMO (VA-ECMO), including thrombus formation, bleeding, and hemolysis, remain significant challenges that impact patient outcomes and healthcare costs. These complications primarily arise from blood-material interactions within the ECMO circuit, necessitating the development of biocompatible materials to optimize hemocompatibility. This review provides an updated overview of the latest advancements in VA-ECMO materials, focusing on cannula, oxygenators, and centrifugal pumps. Various surface modifications, such as heparin coatings, nitric oxide-releasing polymers, phosphorylcholine (PC)-based coatings, and emerging omniphobic surfaces, have been explored to mitigate thrombosis and bleeding risks. Additionally, novel oxygenator membrane technologies, including zwitterionic polymers and endothelial-mimicking coatings, offer promising strategies to enhance biocompatibility and reduce inflammatory responses. In centrifugal pumps, magnetic levitation systems and hybrid polymer-composite impellers have been introduced to minimize shear stress and thrombogenicity. Despite these advancements, no single material has fully addressed all complications, and further research is needed to refine surface engineering strategies. This review highlights the current progress in ECMO biomaterials and discusses future directions in developing more effective and durable solutions to improve patient safety and clinical outcomes.
体外膜肺氧合(ECMO)是治疗严重心功能和呼吸功能衰竭患者的关键生命支持疗法。然而,静脉-动脉体外膜肺氧合(VA-ECMO)相关的并发症,包括血栓形成、出血和溶血,仍然是影响患者预后和医疗成本的重大挑战。这些并发症主要源于ECMO回路内的血液-材料相互作用,因此需要开发生物相容性材料以优化血液相容性。本综述提供了VA-ECMO材料最新进展的最新概述,重点关注插管、氧合器和离心泵。人们探索了各种表面改性方法,如肝素涂层、一氧化氮释放聚合物、基于磷酰胆碱(PC)的涂层以及新兴的超疏液表面,以降低血栓形成和出血风险。此外,新型氧合器膜技术,包括两性离子聚合物和内皮模拟涂层,为增强生物相容性和减少炎症反应提供了有前景的策略。在离心泵中,引入了磁悬浮系统和混合聚合物复合叶轮,以尽量减少剪切应力和血栓形成倾向。尽管取得了这些进展,但没有一种材料能完全解决所有并发症,仍需要进一步研究以完善表面工程策略。本综述强调了ECMO生物材料的当前进展,并讨论了开发更有效、更耐用的解决方案以提高患者安全性和临床预后的未来方向。